Life-threatening sublingual hematoma in a severely hemophilic patient with factor VIII inhibitor.
The management of a patient with Factor VIII inhibitor in whom a marked hematoma of the sublingual region developed is described. Administration of activated prothrombin complex concentrates and nasotracheal intubation with the fiberoptic laryngoscopy were used in the management of this patient.
D000328:Adult; D001779:Blood Coagulation Factors / Q000008:administration & dosage / Q000627:therapeutic use*; D005164:Factor IX / Q000008:administration & dosage / Q000627:therapeutic use*; D015949:Factor IXa; D005169:Factor VIII / Q000037:antagonists & inhibitors*; D006406:Hematoma / Q000188:drug therapy*; D006467:Hemophilia A / Q000097:blood*; D006490:Hemostatics / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D014060:Tongue Diseases / Q000188:drug therapy*
D001779:Blood Coagulation Factors; D006490:Hemostatics; D005169:Factor VIII; D005164:Factor IX; D015949:Factor IXa